Publicaciones (32) Publicaciones de FLOR ANGEL ORDOÑEZ ALVAREZ

2024

  1. β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease

    Nefrologia, Vol. 44, Núm. 1, pp. 90-99

2023

  1. β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease

    Nefrologia

2022

  1. Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation

    Kidney International Reports, Vol. 7, Núm. 4, pp. 797-809

2021

  1. Bone Disease in CKD in Children

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 423-438

  2. Molecular Mechanisms of Proteinuria in Minimal Change Disease

    Frontiers in Medicine, Vol. 8

  3. Tratamiento del cólico nefrítico

    Nefrología pediátrica (Ediciones de la Universidad de Oviedo), pp. 1037-1040

2019

  1. 14.5 Tubulopatías primarias.

    Manual de pediatría (Ergon), pp. 1178-1183

2017

  1. Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine

    Pediatric Research, Vol. 82, Núm. 1, pp. 148-154

  2. Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome

    PLoS ONE, Vol. 12, Núm. 3

2015

  1. Anomalías nefrourológicas congénitas. Una visión para el pediatra

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 83, Núm. 6, pp. 442-442

  2. Chronic kidney disease induced by adenine: A suitable model of growth retardation in uremia

    American Journal of Physiology - Renal Physiology, Vol. 309, Núm. 1, pp. F57-F62

  3. Clinical and laboratory approaches in the diagnosis of renal tubular acidosis

    Pediatric Nephrology, Vol. 30, Núm. 12, pp. 2099-2107

2014

  1. Enfermedad renal crónica

    Tratado de pediatría (Editorial Médica Panamericana), pp. 2029-2033

  2. Tubulopatías primarias

    Tratado de pediatría (Editorial Médica Panamericana), pp. 2004-2009

2013

  1. Dent’s disease: Identification of seven new pathogenic mutations in the CLCN5 gene

    Journal of Pediatric Genetics, Vol. 2, Núm. 3, pp. 133-140

  2. Genetics of Type III Bartter Syndrome in Spain, Proposed Diagnostic Algorithm

    PLoS ONE, Vol. 8, Núm. 9

  3. Hormone therapy to improve growth in infants with chronic kidney disease

    Nutrition in Infancy (Humana Press Inc.), pp. 165-174

  4. Hypophosphatemia and growth

    Pediatric Nephrology, Vol. 28, Núm. 4, pp. 595-603

2012

  1. Growth hormone improves growth retardation induced by rapamycin without blocking its antiproliferative and antiangiogenic effects on rat growth plate

    PLoS ONE, Vol. 7, Núm. 4

2009

  1. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: Effect of growth hormone treatment

    American Journal of Physiology - Renal Physiology, Vol. 297, Núm. 3